Quest Diagnostics Announces Opioid Therapy Genetic Test

The company said it is believed to be the first clinical lab to offer testing for variants in all cytochrome P450 genes known to influence the CYP450 enzyme system, which affects the metabolism of opioids.

Quest Diagnostics on Aug. 8 announced the availability of a new, lab-developed genetic test to aid in the delivery of personalized opioid pain-relieving treatment, with the company saying it is believed to be the first clinical lab to offer testing for variants in all cytochrome P450 (CYP450) genes known to influence the CYP450 enzyme system, which affects the metabolism of opioids and other medications. With it, physicians can predict the rate of opioid drug metabolism and then adjust dosages or use other therapies, reducing the likelihood of drug toxicity, drug interactions, and other adverse outcomes, according to the company.

Millions of Americans suffer from chronic pain, and opioids are frequently used for pain management. Opioids also have high rates of drug addiction and overdose in the United States.

The company's announcement said the new test is based in part on gene variants owned by Transgenomic, Inc. through a non-exclusive licensing agreement between it and Quest Diagnostics, which developed, validated, and now offers the test service through its Nichols Institute facility in San Juan Capistrano, Calif.

"Genetic testing to personalize the use of pain-alleviating drug therapies is an exciting new clinical field with tremendous potential to promote favorable outcomes for the many millions of individuals struggling with pain," said Dr. Charles Strom, MD, Ph.D., senior medical director, Genetics, for Quest Diagnostics. "Opioids can be very effective pain-alleviating medications, but they are also powerful and potentially dangerous drugs carrying a high risk of addiction, toxicity, and other adverse effects. The inclusion of Transgenomic's gene discoveries into our genetic testing services will provide physicians with greater insights for safely and effectively administering opioid treatment."

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • The Top 5 Safety and Technology Trends to Watch in 2019

    Get the latest on trends you can expect to hear more about in 2019, including continued growth of mobile safety applications, wearable technology, and smart PPE; autonomous vehicles; pending OSHA recordkeeping rulemaking; and increased adoption of international safety standard, ISO 45001.

  • Get the Ultimate Guide to OSHA Recordkeeping

    OSHA’s Form 300A posting deadline is February 1! Are you prepared? To help answer your key recordkeeping questions, IndustrySafe put together this guide with critical compliance information.

  • Safety Training 101

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common training questions.

  • Conduct EHS Inspections and Audits

    Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Industry Safe

OH&S Digital Edition

  • OHS Magazine Digital Edition - January 2019

    January 2019

    Featuring:

    • PREVENTING ERRORS
      Production vs. Safety 
    • EMERGENCY SHOWERS & EYEWASH
      Meeting the Requirements for Emergency Equipment
    • CONSTRUCTION SAFETY
      The State of Contractor Safety
    • FOOT PROTECTION
      The Three Keys to Effective Chemical Management
    View This Issue